goralatide has been researched along with fosinopril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azizi, M; Corvol, P; Massien, C; Michaud, A | 1 |
| Azizi, M; Bissery, A; Guyene, TT; Labatide-Alanore, A; Lamarre-Cliche, M; Ménard, J | 1 |
2 trial(s) available for goralatide and fosinopril
| Article | Year |
|---|---|
In vitro and in vivo inhibition of the 2 active sites of ACE by omapatrilat, a vasopeptidase inhibitor.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Catalytic Domain; CHO Cells; Cricetinae; Cross-Over Studies; Double-Blind Method; Fosinopril; Humans; Hydrolysis; Kinetics; Male; Molecular Sequence Data; Neprilysin; Oligopeptides; Peptidyl-Dipeptidase A; Pyridines; Sodium; Substrate Specificity; Thiazepines | 2000 |
Physiologic consequences of vasopeptidase inhibition in humans: effect of sodium intake.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Double-Blind Method; Endothelin-1; Endothelins; Fosinopril; Humans; Male; Neprilysin; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Protein Precursors; Pyridines; Renin; Sodium, Dietary; Thiazepines; Time Factors | 2002 |